- Home
- VNDA vs AVNW Comparison
VNDA vs AVNW Comparison
Compare VNDA & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- AVNW
- Stock Information
- Founded
- VNDA 2002
- AVNW 2006
- Country
- VNDA United States
- AVNW United States
- Employees
- VNDA N/A
- AVNW N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- AVNW Radio And Television Broadcasting And Communications Equipment
- Sector
- VNDA Health Care
- AVNW Technology
- Exchange
- VNDA Nasdaq
- AVNW Nasdaq
- Market Cap
- VNDA 249.4M
- AVNW 274.4M
- IPO Year
- VNDA 2006
- AVNW 2007
- Fundamental
- Price
- VNDA $5.47
- AVNW $24.39
- Analyst Decision
- VNDA Strong Buy
- AVNW Strong Buy
- Analyst Count
- VNDA 2
- AVNW 3
- Target Price
- VNDA $16.50
- AVNW $32.00
- AVG Volume (30 Days)
- VNDA 562.7K
- AVNW 78.8K
- Earning Date
- VNDA 10-29-2025
- AVNW 11-05-2025
- Dividend Yield
- VNDA N/A
- AVNW N/A
- EPS Growth
- VNDA N/A
- AVNW N/A
- EPS
- VNDA N/A
- AVNW 0.10
- Revenue
- VNDA $203,467,000.00
- AVNW $434,606,000.00
- Revenue This Year
- VNDA $15.45
- AVNW $5.75
- Revenue Next Year
- VNDA $37.82
- AVNW $6.82
- P/E Ratio
- VNDA N/A
- AVNW $243.20
- Revenue Growth
- VNDA 11.78
- AVNW 6.50
- 52 Week Low
- VNDA $3.81
- AVNW $12.96
- 52 Week High
- VNDA $5.59
- AVNW $26.83
- Technical
- Relative Strength Index (RSI)
- VNDA 63.56
- AVNW 59.75
- Support Level
- VNDA $5.22
- AVNW $22.71
- Resistance Level
- VNDA $5.45
- AVNW $23.82
- Average True Range (ATR)
- VNDA 0.21
- AVNW 0.83
- MACD
- VNDA -0.01
- AVNW 0.16
- Stochastic Oscillator
- VNDA 73.96
- AVNW 92.36
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.